金红方治疗脓毒症的随机对照试验与网络药理学机制研究
本研究通过单中心随机对照试验评估金红方治疗脓毒症的临床疗效,并借助网络药理学探索其机制。共纳入114例患者,结果显示金红方可显著降低28天和60天全因死亡率,改善第7天SOFA评分,并具有抗炎和抗氧化(SOD)作用。网络药理学识别出72个活性成分和426个靶基因,富集分析提示IL-17和TNF信号通路在炎症反应和免疫调节中起重要作用。
要点
- 金红方可降低脓毒症患者28天和60天全因死亡率。
- 金红方可改善脓毒症患者第7天SOFA评分。
- 金红方具有抗炎和抗氧化作用,机制可能涉及IL-17和TNF信号通路。
核心结论
- 金红方含有潜在的抗炎和抗氧化活性物质,可能通过IL-17和TNF信号通路发挥作用。
- 对于脓毒症,金红方可能是一种有前景且有效的治疗策略。
研究设计与样本
- 单中心随机对照临床试验评估金红方治疗脓毒症的疗效,共纳入114例患者。
- 利用中药药理学数据库和分析平台识别金红方的活性成分和治疗靶点。
- 使用多种疾病靶点数据库筛选脓毒症治疗靶蛋白,构建蛋白-蛋白相互作用网络并进行GO/KEGG富集分析。
主要发现
- 与未使用金红方的参与者相比,金红方显著降低干预后28天和60天全因死亡率。
- 金红方显著改善干预后第7天序贯器官衰竭评估(SOFA)评分。
- 金红方具有抗炎和抗氧化(SOD)作用。
- 网络药理学分析识别出72个活性成分和426个靶基因,成功构建「金红方-化合物靶点-脓毒症」网络。
- GO/KEGG富集分析揭示的116个靶点通过白细胞介素-17(IL-17)和肿瘤坏死因子(TNF)信号通路在炎症反应和免疫调节中发挥显著作用。
关键数值与推荐
- 共纳入114例患者进行随机对照试验。
- 金红方显著降低28天和60天全因死亡率。
- 金红方显著改善第7天SOFA评分。
- 识别出72个活性成分和426个靶基因。
- 116个靶点通过IL-17和TNF信号通路参与炎症反应和免疫调节。
临床怎么用
- 金红方可能作为脓毒症的治疗选择,具有降低死亡率和改善器官功能的潜力。
- 临床应用时可关注其抗炎和抗氧化效应,并考虑IL-17和TNF信号通路相关机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: JinHong Formula (JHF) was derived from the famous Rhubarb and Moutan Decoction which was prescribed for appendicitis. It was originally recorded in the classic of "Jingui Yaolve" written by Zhang Zhongjing. It is a kind of traditional Chinese medicine, widely used in the treatment of inflammation. However, the clinical effect of JHF for sepsis and its comprehensive mechanism in sepsis remained largely unknown. RESEARCH PURPOSE: The aim of our study was to evaluate the clinical effect of JHF in the treatment of sepsis, and to explore its mechanism from the perspective of network pharmacology. RESEARCH METHODS: The single-center randomized clinical trial was conducted to assess the effect of JHF in the treatment of sepsis. Additionally, we used the Chinese herbal medicine pharmacology database and analysis platform to identify the active components and therapeutic target of JHF. Numerous well-known disease target databases have been used to screen therapeutic target proteins for sepsis. Furthermore, we have established a Protein-Protein Interaction (PPI) network and carried out Gene Onotology/Kyoto Encyclopedia of Genes and Genomes (GO/KEGG) enrichment analysis. In order to conclude which active compounds from JHF may be responsible for signaling pathway, we performed network analysis. RESEARCH RESULTS: The study included 114 patients. By comparing participants with and without JHF, the results suggested that JHF significantly reduced all-cause mortality on 28 and 60 days after intervention, and improved Sequential Organ Failure Assessment (SOFA) on 7th day after intervention as well as. JHF had an effect of anti-inflammatories and antioxidants (SOD). By using network pharmacological analysis, we identified 72 active components and 426 target genes of JHF, and successfully constructed a "JHF-compound target-sepsis" network. 116 mentioned targets revealed by GO/KEGG enrichment analysis played a significant role in the inflammatory reaction and immunoregulation via interleukin-17 (IL-17) and tumor necrosis factor (TNF) signaling pathway. Moreover, the analysis of "pathway target-active component" revealed that Sennidin A, Rheidin A, Rheidin B, Rheidin C, (E)-4-Phenyl-3-Buten-2-One, Osmanthuside H, Esculetin, and Caffeicacid were responsible for IL-17, TNF signaling pathways. CONCLUSION: JHF contains potential active substance of anti-inflammatory and antioxidant. These active compounds may come into play through IL-17 and TNF signaling pathways. For sepsis, JHF may be a promising and effective treatment strategy.
引用
- Wu X, He C, Liu C, et al. Mechanisms of JinHong Formula on treating sepsis explored by randomized controlled trial combined with network pharmacology. J Ethnopharmacol. 2022. PMID: 36539071. doi:10.1016/j.jep.2022.116040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。